Letter: Use of Collagen Proportionate Area to Quantify Liver Fibrosis and Predict Clinical Outcomes in Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Use of Collagen Proportionate Area to Quantify Liver Fibrosis and Predict Clinical Outcomes Non-Alcoholic Fatty Liver Disease-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Current Modalities of Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Translational Hepatology
2017English

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2014English

Sarcopenia Is Associated With Severe Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Letter: Would Aspirin Alleviate Fibrosis in Alcoholic Liver Disease?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy